"10.1371_journal.pone.0005853","plos one","2009-06-10T00:00:00Z","Irina Tcherepanova; Aijing Starr; Brad Lackford; Melissa D Adams; Jean-Pierre Routy; Mohamed Rachid Boulassel; David Calderhead; Don Healey; Charles Nicolette","Research and Development Department, Argos Therapeutics, Inc. Durham, North Carolina, United States of America; Duke Clinical Research Institute, Durham, North Carolina, United States of America; National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, United States of America; BD Diagnostics, Durham, North Carolina, United States of America; McGill University Health Center and INSERM Unit 743, Montr√©al, Canada","Conceived and designed the experiments: IT DC DH CAN. Performed the experiments: IT AS BL MA DC. Analyzed the data: IT AS BL MA MRB DC. Contributed reagents/materials/analysis tools: IT JPR. Wrote the paper: IT MRB DH CAN. Provided samples for the study: JPR.","At the time of work conducted the following authors were employed by Argos: Irina Tcherepanova, Aijing Starr, Brad Lackford, Melissa D. Adams, David Calderhead, Don Healey and Charles Nicolette. Presently the following authors are employed by Argos: Irina Tcherepanova, David Calderhead, Don Healey and Charles Nicolette. The following authors own a stock options of Argos Therapeutics: Irina Tcherepanova, Aijing Starr, Brad Lackford, Melissa D. Adams, David Calderhead, Don Healey and Charles Nicolette. Argos Therapeutics Inc. is not publically traded Company. None of authors are members of the Board of Directors. The work is not associated with any pending or filed patent application. The funds did not come from Research grant, Travel grant or a Gift. The work was funded by Venture capital and the funders did not have any influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.","2009","06","Irina Tcherepanova","IT",9,TRUE,4,5,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
